Lilly's oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial
Investors | Eli Lilly and Company   14 hours ago
ads
Read Full Story
Lilly's oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial  Eli Lilly and CompanyEli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial  CNBCDaily weight loss pill can help cut body...